Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 65
  • Home
  • Print this page
  • Email this page

 Table of Contents  
Year : 2017  |  Volume : 12  |  Issue : 5  |  Page : 346-352

Factors affecting liposomes particle size prepared by ethanol injection method

1 Department of Pharmaceutical Research, Faculty of Pharmacy and Drug Technology, Heliopolis University for Sustainable Development, 2834 El Horreya, Cairo, Egypt
2 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy Suez Canal University, Ismailia, Egypt

Date of Web Publication13-Sep-2017

Correspondence Address:
Sherif Shaker
Department of Pharmaceutical Research, Faculty of Pharmacy and Drug Technology, Heliopolis University for Sustainable Development, 2834 El Horreya, Cairo
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1735-5362.213979

Rights and Permissions

Ethanol injection is one of the techniques frequently used to produce liposomes which favors both simplicity and safety. In this process, an ethanolic solution of lipids is rapidly injected into an aqueous medium through a needle, dispersing the phospholipids throughout the medium and promoting the vesicle formation. Being a critical parameter that determines the fate of liposome and its distribution, we studied different factors affecting the particle size of liposomes including different phospholipid (Phosal® 53 MCT) and cholesterol concentrations and the use of different types of non-ionic surfactants at fixed Phosal® 53 MCT concentration of 50 mg per formulation. Both Phosal® 53 MCT and cholesterol concentration had direct effect on liposomes particle size. Non-ionic surfactants produced liposomes of smaller particle size when compared to conventional liposomes formed using Phosal® 53 MCT 300 mg per formulation only, whereas this effect was diminished when higher Phosal® 53 MCT to cholesterol ratios were used that obviously increased liposomes size. Smaller liposomes sizes were obtained upon using non-ionic surfactants of lower hydrophilic/hydrophobic balance (HLB) as both Tween 80 and Cremophor RH 40 produced liposomes of smaller particle size compared to Poloxamer 407. The smallest liposomes particle size was successfully obtained in the formulation comprising 300 mg Phosal® MCT, 150 mg cholesterol and 50 mg Tween 80.

Keywords: Phosal® 53 MCT; Cholesterol; Nonionic surfactants; Liposomes

How to cite this article:
Shaker S, Gardouh AR, Ghorab MM. Factors affecting liposomes particle size prepared by ethanol injection method. Res Pharma Sci 2017;12:346-52

How to cite this URL:
Shaker S, Gardouh AR, Ghorab MM. Factors affecting liposomes particle size prepared by ethanol injection method. Res Pharma Sci [serial online] 2017 [cited 2022 Dec 2];12:346-52. Available from: https://www.rpsjournal.net/text.asp?2017/12/5/346/213979

  Introduction Top

Over the last decades, liposomes have been thoroughly investigated as drug delivery systems for variety of drugs and routes of administration. Liposomes are formed when amphiphilic lipids organize themselves spontaneously in bilayer vesicles as a result of interactions between phospholipids and water [1]. As these lipid vesicles possess lipophilic and hydrophilic portions, they can entrap substances with different polarities either in the phospholipid bilayer or the aqueous compartment or at the bilayer interfaces [2], which can modify physicochemical properties and can enhance biological activity of entrapped compounds [3].

Several techniques were reported in literature for the preparation of liposome suspensions. Ethanol injection method was first reported in the early 1970s by Batzri and Korn [4]. It involves the dissolution of phospholipids into an organic solvent and further dispersion of the lipids into water. This immediate dilution of ethanol in the aqueous phase causes the lipid molecules to precipitate and form bilayer planar fragments which further transform into liposomal system [5]. This method is simple, rapid and easy to scale-up.

Liposomes particle size is one such property that affects the half-life of liposomes in the vascular system and may range from few minutes to many hours. The particle size has an influence on the vesicles removal from circulation by the reticuloendothelial system, phagocytosis by kupffer cells, distribution and accumulation in specific organs [6]. Smaller liposomes (0.1-1 µm) are located principally in the liver and spleen whereas liposomes larger than 3 µm are deposited in the lungs.

Effect of surfactant on liposomes particle size was previously studied using only one type of surfactant (Tween 80) with various phospholipid/cholesterol ratios [7]. Another study was also performed using different types of surfactants at fixed phospholipid/cholesterol ratio [8]. Therefore, the purpose of this work was to demonstrate the effects of Phosal® 53 MCT and cholesterol concentrations as well as the type of nonionic surfactants on the liposomes particle size. In this study we produced liposomes of desirable size from an optimized formulation comprising Phosal® 53 MCT, cholesterol and a surfactant.

  Materials and Methods Top


Phosal® 53 MCT was provided by Phospholipid GmbH (Germany), which is composed of phosphatidylcholine 53% w/w, lysophosphatidylcholine 6% w/w, medium chain triglycerides (caprylic/capric triglycerides), alcohol 3-6% w/w, glyceryl stearate, oleic acid and ascorbyl palmitate [9]. Cholesterol, Cremophor RH40, poloxamer 407 and Tween 80, ethanol 96% were obtained from Sigma- Aldrich (St. Louis, USA). Purified water was obtained by double distillation.

Liposome preparation

Liposomes were prepared by ethanol injection method [8]. Phosal® 53 MCT, cholesterol and surfactant were dissolved in ethanol 96%. The resultant organic phase was gently heated at 40 ±2°C to improve the solubility of cholesterol and miscibility of Phosal® 53 MCT. The volume of organic phase was adjusted to 15 mL to dissolve the highest amount of cholesterol (150 mg) used in this study, without any precipitation in the needle during injection. The ethanolic solution was then injected into 85 mL preheated water at 60 ± 5°C. The injection rate was fixed to 500 µL/min. Liposomes formed spontaneously with continuous stirring at 500 rpm using a magnetic stirrer. Ethanol was evaporated by means of a rotary evaporator (Heidolph, Germany). The effects of various concentrations of Phosal® 53 MCT, cholesterol, and surfactant types including Tween 80, Cremophor RH 40, and Poloxamer 407 were evaluated on the liposome particle size.

Size distribution analysis

The mean size and polydispersity index of the liposomal preparations were measured by laser diffraction analyzer (Malvern Inc., Worcestershire, UK). Each sample was diluted with water until the appropriate concentration of particles was achieved and measured. All measurements were performed in triplicate at 25°C.

Statistical analysis

All experiments were repeated three times and expressed as the mean ± standard deviation. One way analysis of variance (ANOVA) was used to substantiate statistical differences between groups in each series of experiment. Results with P < 0.05 were considered significant.

  Results Top

The effect of different Phosal® 53 MCT concentrations on liposome particle size

In this study, three different liposome dispersions of Phosal® 53 MCT at 300, 600 and 900 mg, but without cholesterol or surfactants were prepared according to the method already described. The average particle sizes ± SD were found to be 268 ± 15.2, 453 ± 11.5 and 913 ± 35 nm, respectively. The polydispersity indices ± SD were found to be 0.671 ± 0.027, 0.864 ± 0.024 and 0.502 ± 0.052, respectively.

The effect of different cholesterol concentrations on liposome particle size

Amounts of 50, 100 and 150 mg of cholesterol were used with Phosal® 53 MCT in the preparation of liposome dispersion without any surfactants. Cholesterol caused an increase in the liposomes particle size compared to blank liposomes. It was found that increasing cholesterol concentrations had direct effect on increasing liposomes particle size significantly. However, the addition of 50 mg cholesterol to 300 and 900 mg Phosal® 53 MCT and 100 mg cholesterol to 300 mg Phosal® 53 MCT, did not significantly increase liposomes particle size compared to their respective control in each series [Figure 1].
Figure 1: Effect of different cholesterol (CH) concentrations on the mean particle size of liposomes comprising various Phosal® 53 MCT (PH) concentrations without surfactant. C denotes the control liposomes. *Means are significant at P < 0.05; **means are significant at P < 0.01; +means are not significant (P > 0.05).

Click here to view

As seen, higher concentrations of Phosal® 53 MCT also produced liposomes of larger particle size.

The effect of surfactant types on liposomes particle size

In our study, we investigated the effects of three nonionic surfactants Cremophor RH 40, Poloxamer 407 and Tween 80 on liposomes size. They were used at a fixed amount of 50 mg with different Phosal® 53 MCT concentrations in the absence of cholesterol as shown in [Figure 2]. Nonionic surfactants were only able to reduce the size of liposomes of Phosal® 53 MCT at 300 mg level. However addition of surfacants to higher concentrations of Phosal® 53 MCT increased the size of liposomes significantly. The liposomes size increased on increasing Phosal® 53 MCT concentrations at 600 and 900 mg. The order of liposomes particle size prepared from various surfactants was found to be for Tween 80 < Cremophor RH 40 < Poloxamer 407 at all different Phosal® 53 MCT concentrations.
Figure 2: The effect of surfactant type Tween 80 (ST), Cremophor RH 40 (SC), Poloxamer 407 (SP) and No surfactant (NS) on the mean particle size of liposomes comprising different Phosal® 53 MCT (PH) concentrations without cholesterol. C indicates control liposomes.*Means are significant at P < 0.05; **means are significant at P < 0.01; +means are not significant (P > 0.05).

Click here to view

The effect of different cholesterol concentrations and surfactant types on liposomes particle size

The influence of cholesterol concentration and the type of surfactant on the mean particle size of Phosal® 53 MCT liposomes is depicted in [Figure 3]a. As seen in this figure, the addition of cholesterol to the formulations increased the size of liposome. This increase was significant only when 50 mg cholesterol was combined with Cremophor RH 40 and Poloxamer 407. As seen in [Figure 3]b, the addition of various cholesterol concentrations significantly increased the size of liposomes composed of Poloxamer 407. On the contrary, the addition of cholesterol 50 and 100 mg to Tween 80 and Cremophor RH 40 did not significantly increase the size of liposomes.
Figure 3: Effect of different cholesterol concentrations and surfactant types on the mean particle size of liposomes comprising (A) 300 mg Phosal® 53 MCT, (B) 600 mg Phosal® 53 MCT and (C) 900 mg Phosal® 53 MCT. C denotes the control liposomes. *Means are significant at P < 0.05; **means are significant at P < 0.01; +means are not significant (P > 0.05).

Click here to view

Liposomes comprising Phosal® 53 MCT, surfactant and 50 mg cholesterol had larger particle size than counterpart liposome formulations. However, cholesterol addition to liposome formulations comprising no surfactant increased the particle size in a concentration-dependent manner. It was observed that at higher ratio of Phosal® 53 MCT to cholesterol liposomes of larger sizes were obtained [7]. Addition of Poloxamer 407 had a significant effect on increasing liposomes mean particle size at higher Phosal® 53 MCT to cholesterol ratios. Poloxamer 407 increased liposomes particle size, as compared to Tween 80 and Cremophor RH 40. On the other hand, Tween 80 was able to produce liposomes of smaller particle sizes when compared to Cremophor RH 40 at all Phosal® 53 MCT concentrations despite their close HLB values [Figure 3]b and [Figure 3]c.

  Discussion Top

Phospholipids are the main constituent of liposomal membrane, thus they can have a direct effect on liposomes particle size [10]. In this study, the increase of Phosal® 53 MCT concentrations in the aqueous phase enhanced the viscosity of the dispersion as well as the particle size. It has been reported in the Wu YN, et al. study that particle size of papain liposomes decreases with decreasing phosphatidylcholine concentration [10]. Liposomes of lower amounts of phospholipid (phosphatidylcholine 50%), were smaller in the size than liposomes of a higher amount of phospholipid (phosphatidylcholine 95%) [11].

Cholesterol is often included in liposomes formulation to give further rigidity to the bilayer and improve the physical stability of liposomes [12]. Cholesterol enhances the retention of entrapped solutes and reduces serum-induced instability. An increase in cholesterol content in liposomes results in a dramatic decrease in membrane permeability for solutes [13]. Cholesterol doesn't form a bilayer itself but it is dissolved in the phospholipid bilayer [14]. As the concentration of cholesterol increases more cholesterol molecules will be distributed in the phospholipid bilayer, causing an increase in the liposome mean diameter at all Phosal® 53 MCT concentrations. It has been reported that higher cholesterol concentrations interferes with the close packing of the phospholipid bilayer by contributing to an increase in membrane fluidity which results in an increased distribution of aqueous phase within the liposomal vesicles [15]. This explains the direct increase of liposomes mean diameter observed with cholesterol concentrations up to 150 mg in the formulations.

Surfactants were used at a fixed amount of 50 mg. At low concentrations, the surfactant molecules were taken up into the liposome membrane without breaking up the vesicle. As the concentration increases, the proportion of surfactant molecules in the membrane increases until a critical value. Above this threshold value, rupture of parts of the membrane is induced [10]. Therefore, the concentrations of surfactants need to be carefully selected to ascertain vesicle formation [16]. Incorporation of tween 80 in liposomes (0 to 0.2 molar ratio, Tween 80: lipids) caused a dramatic decrease in liposomal size due to steric repulsion rendered by surfactant molecules which prevents or minimizes the aggregation of the vesicles [16]. The results of our study suggest that at higher Phosal® 53 MCT concentrations the effect of surfactants was counterbalanced by the effect of Phosal® 53 MCT concentrations to increase the liposomal size. By comparing the effect of different surfactants, it seems to exist a rational relationship between lipophilicity (HLB values) of surfactants and mean particle sizes; increasing the HLB value resulted in larger liposomes [17]. The HLB values for Tween 80, Cremophor RH 40 and Poloxamer 407 were 15, 14-16 and 18-23 respectively which explains the increasing order of liposomes size. The physical state of surfactants may also partially explain the size difference, where Tween 80 has a liquid nature, Cremophor RH 40 is a paste, and Poloxamer 40 is a solid at 25°C.

The liposomes particle size was influenced by the surfactant type and the ratio between Phosal® 53 MCT and cholesterol. As with some other studies, it was observed that as the ratio of Phosal® 53 MCT to cholesterol increased the particle size [9].

On using Phosal® 53 MCT 300 mg, it was expected that the particle size increase, as reported in literature, but the surfactant effect to lower particle size was more prominent than cholesterol enlarging effect [9], owing to surfactant steric repulsion among surfactant molecules [16]. Moreover, cholesterol might increase the rigidity of the phospholipids bilayer and decrease their fusion to larger vesicles [18].

On the other hand, at higher Phosal® 53 MCT concentrations (600 and 900 mg), the effect of the surfactant to lower liposomes particle size was opposed by the higher Phosal® 53 MCT to cholesterol ratios which obviously tended to increase liposomes size. In addition, increasing cholesterol concentrations might interfere with the close packing of the phospholipid bilayer [19].

The influence of high HLB values of surfactant on increasing the liposome particle size was strongly supported with high Phosal® 53 MCT concentrations [18]. Despite close HLB values of Tween 80 and Cremophor RH 40, the latter gave lower liposome sizes. This behavior might be attributed to the branched structure and relative bulkiness of the Cremophor RH 40 molecules leading to increased size of the vesicles [19].

  Conclusion Top

Both Phosal® 53 MCT and cholesterol increased the liposomes particle size in a concentration-dependent manner. However the addition of a surfactant lowered the liposomes particle size at Phosal® 53 MCT 300 mg with either cholesterol 100 or 150 mg per formulation. The type of surfactant had an influence on liposomes particle size; Tween 80 was the surfactant of choice. Liposomes of smaller particle size were obtained with 300 mg Phosal® 53 MCT, 50 mg Tween 80 (non- ionic surfactant) and 150 mg Cholesterol.

  Acknowledgements Top

The authors would thank the quality control department of ATOS Pharma for providing us with the chemicals needed in our experiments. The completion of the statistical analysis couldn't have been possible without the expertise of Dr. Zainab Zakaria, Post Doc. Researcher, Biomedical Research Lab, Faculty of Pharmacy, Heliopolis University for sustainable development.

  References Top

Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm. 2009;7:161-172.  Back to cited text no. 1
Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154:123-140.  Back to cited text no. 2
Gortzi O, Lalas S, Chinou I, Tsaknis J. Evaluation of the antimicrobial and antioxidant activities of Origanum dictamnus extracts before and after encapsulation in liposomes. Molecules. 2007;12: 932-945.  Back to cited text no. 3
Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta. 1973;298(4):1015-1019.  Back to cited text no. 4
Wagner A, Vorauer-Uhl K. Liposome technology for industrial purposes. Drug Deliv. 2011; 2011: 591325. doi: 10.1155/2011/591325.  Back to cited text no. 5
Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res. 2010;20:228–243.  Back to cited text no. 6
Ma J, Guan R, Ri C, Liu M, Ye X, Jiang J. Response surface methodology for the optimization of lactoferrin nano-liposomes. Adv Food Sci Tec. 2012;4(5):249-256.  Back to cited text no. 7
Song J, Shi F, Zhang Z, Zhu F, Xue J, Tan X, et al. Formulation and evaluation of Celastrol-loaded liposomes. Molecules. 2011;16(9):7880-7892.  Back to cited text no. 8
Fricker G, Kromp T,Wendel A, Blume A, Zirkel J, Rebmann H, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010;27(8):1469-1486.  Back to cited text no. 9
Wu YN, Xu YL, Sun WX. Preparation and particle size controlling of papain nanoliposomes. J Shanghai Jiaotong Univ Agric Sci. 2007;25:105-109.  Back to cited text no. 10
Taghizadeh SM, Bajgholi S. A new liposomal-drug- in-adhesive patch for transdermal delivery of sodium diclofenac. J Biomater Nanobiotechnol. 2011;2:576-581.  Back to cited text no. 11
Liang X, Mao G, Ng KY. Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. J Colloid Interface Sci. 2004;278:53–62.  Back to cited text no. 12
Tseng LP, Liang HJ, Chung TW, Huang YY, Liu DZ, et al. Liposomes incorporated cholesterol for drug release triggered by magnetic field. J Med Biol Eng. 2007;27(1):29-34.  Back to cited text no. 13
Melzak KA, Melzak SA, Gizeli E, Toca-Herrera JL. Cholesterol organization in phosphatidylcholine liposomes: A surface plasmon resonance study. Materials. 2012;5:2306-2325.  Back to cited text no. 14
Duangjit S, Pamornpathomkul B, Opanasopit P, Rojanarata T, Obata Y, Takayama K, et al. Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam- loaded liposomes. Int J Nanomedicine. 2014;9:2005-2017.  Back to cited text no. 15
Xia S, Xu S. Ferrous sulfate liposomes: preparation, stability and application in fluid milk. Food Res Int. 2005;38:289-296.  Back to cited text no. 16
Khazaeli P, Pardakhty A, Shoorabi H.Caffeine-loaded niosomes: characterization and in vitro release studies. Drug Deliv. 2007;14(7):447-452.  Back to cited text no. 17
Akhilesh D, Bini KB, Kamath JV. Review on span 60 based non-ionic surfactant vesicles (Niosomes) as novel drug delivery. IJRPBS. 2012;3:1-12.  Back to cited text no. 18
Ali AM, Sarhan HA, Magdy T. Preparation and characterization of phenytoin sodium niosomes for enhanced closure of skin injuries. Int J Pharm Pharm Sci. 2014;6:542-546.  Back to cited text no. 19


  [Figure 1], [Figure 2], [Figure 3]

This article has been cited by
1 Systematic Development and Optimization of Teriparatide-Loaded Nanoliposomes Employing Quality by Design Approach for Osteoporosis
Dhwani Rana, Sagar Salave, Sonali Jain, Ravi Shah, Derajram Benival
Journal of Pharmaceutical Innovation. 2022;
[Pubmed] | [DOI]
2 Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery
Poloko Stephen Kheoane, Gillian Mary-Anne Enslin, Clemence Tarirai
Drug Delivery and Translational Research. 2022;
[Pubmed] | [DOI]
3 Liposomes as biocompatible and smart delivery systems – The current state
Michal Dymek, Elzbieta Sikora
Advances in Colloid and Interface Science. 2022; : 102757
[Pubmed] | [DOI]
4 Hybrid liposomes composed of hydrophilic emulsifiers and lecithin: Physicochemical, interaction and curcumin loading properties
Junhua Li, Cuihua Chang, Wanying Chen, Yujie Su, Luping Gu, Yanjun Yang, Jiali Zhai
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2022; : 130210
[Pubmed] | [DOI]
5 Liposomes encapsulating Methylene Blue and Acridine Orange: an approach for phototherapy of skin cancer
Thais P. Pivetta, Quirina Ferreira, Tânia Vieira, Jorge C. Silva, Sandra Simões, Paulo A. Ribeiro, Maria Raposo
Colloids and Surfaces B: Biointerfaces. 2022; : 112901
[Pubmed] | [DOI]
6 Impact of critical process parameters and critical material attributes on the critical quality attributes of liposomal formulations prepared using continuous processing
Gowtham Yenduri, Antonio P. Costa, Xiaoming Xu, Diane J. Burgess
International Journal of Pharmaceutics. 2022; 619: 121700
[Pubmed] | [DOI]
7 An innovative one step green supercritical CO2 process for the production of liposomes co-encapsulating both a hydrophobic and a hydrophilic compound for pulmonary administration
Noémie Penoy, Kouka Luc Delma, Hermane Avohou Tonakpon, Bruno Grignard, Brigitte Evrard, Géraldine Piel
International Journal of Pharmaceutics. 2022; : 122212
[Pubmed] | [DOI]
8 Phyto-therapeutic and nanomedicinal approaches: A new hope for management of Alzheimer’s disease
Nourhan A. Elzayat, Haidy Abbas, Maged W. Helmy, Doaa A. Habib
International Journal of Pharmaceutics. 2022; 627: 122213
[Pubmed] | [DOI]
9 3D nanocomposite alginate hydrogel loaded with pitavastatin nanovesicles as a functional wound dressing with controlled drug release; preparation, in-vitro and in-vivo evaluation
Alaa Emad Eldeeb, Salwa Salah, Mohammed S. Amer, Nermeen A. Elkasabgy
Journal of Drug Delivery Science and Technology. 2022; : 103292
[Pubmed] | [DOI]
10 Carboplatin and decitabine loaded lipid-coated albumin nanoparticles for an efficient treatment of platinum-resistant ovarian cancer
Ozge Esim, Canan Hascicek, Mustafa Emre Gedik, Gurcan Gunaydin, Ayse Lale Dogan
Journal of Drug Delivery Science and Technology. 2022; : 103801
[Pubmed] | [DOI]
11 Nanocochleates as the delivery vehicle for quercetin in the treatment of breast cancer
Meena Tilawat, Smita Bonde
Particulate Science and Technology. 2022; : 1
[Pubmed] | [DOI]
12 Recent advances in liposome development for studying protein-lipid interactions
Samuel Herianto, Boopathi Subramani, Bo-Ruei Chen, Chien-Sheng Chen
Critical Reviews in Biotechnology. 2022; : 1
[Pubmed] | [DOI]
13 Drug-Eluting, Bioresorbable Cardiovascular Stents-Challenges and Perspectives
Julio A. Vallejo-Zamora, Yadira I. Vega-Cantu, Ciro Rodriguez, Geoffrey A. Cordell, Aida Rodriguez-Garcia
ACS Applied Bio Materials. 2022;
[Pubmed] | [DOI]
14 D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against Cutibacterium acnes
Basant A. Habib, Nourtan F. Abdeltawab, Ibtehal Salah Ad-Din
Drug Delivery. 2022; 29(1): 821
[Pubmed] | [DOI]
15 Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats
Mohammed H. Elkomy, Hussein M. Eid, Mohammed Elmowafy, Khaled Shalaby, Ameeduzzafar Zafar, Mohamed A. Abdelgawad, Mostafa E. Rateb, Mohammed R.A. Ali, Izzeddin Alsalahat, Heba A. Abou-Taleb
Drug Delivery. 2022; 29(1): 2694
[Pubmed] | [DOI]
16 Protection of hair color with pomegranate peel extract-loaded liposomal formulation: Preparation, characterization, and ex-vivo activity studies
Sakine Tuncay Tanriverdi, Evren Homan Gokce, Simtac Bengi Filiz, Fadime Aydin Kose, Sedef Kalayci, Ozgen Ozer
Journal of Cosmetic Dermatology. 2022;
[Pubmed] | [DOI]
17 A Nanoliposomal Gel Containing Cinnamomum zeylanicum Essential Oil with Effective Repellent against the Main Malaria Vector Anopheles stephensi
Mahmoud Osanloo, Samira Firoozian, Elham Zarenezhad, Zahra Montaseri, Saha Satvati, Morteza Saki
Interdisciplinary Perspectives on Infectious Diseases. 2022; 2022: 1
[Pubmed] | [DOI]
18 Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery
Muhammad Waseem Akram, Humzah Jamshaid, Fiza Ur Rehman, Muhammad Zaeem, Jehan zeb Khan, Ahmad Zeb
AAPS PharmSciTech. 2022; 23(1)
[Pubmed] | [DOI]
19 Potential Use of Tailored Citicoline Chitosan-Coated Liposomes for Effective Wound Healing in Diabetic Rat Model
Hussein M Eid, Adel A Ali, Ahmed M Abdelhaleem Ali, Essam M Eissa, Randa M Hassan, Fatma I Abo El-Ela, Amira H Hassan
International Journal of Nanomedicine. 2022; Volume 17: 555
[Pubmed] | [DOI]
20 pH-sensitive nanoliposomes for passive and CXCR-4-mediated marine yessotoxin delivery for cancer therapy
Ana MG Vieira, Oscar F Silvestre, Bruno FB Silva, Celso JO Ferreira, Ivo Lopes, Andreia C Gomes, Begoña Espiña, Marisa P Sárria
Nanomedicine. 2022;
[Pubmed] | [DOI]
21 Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study
Omar Awad Alsaidan, Ameeduzzafar Zafar, Mohd Yasir, Sami I. Alzarea, Mohammed Alqinyah, Mohammad Khalid
Gels. 2022; 8(11): 687
[Pubmed] | [DOI]
22 Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures
Mengjie Wang, Chunxin Wang, Shuaikai Ren, Junqian Pan, Yan Wang, Yue Shen, Zhanghua Zeng, Haixin Cui, Xiang Zhao
International Journal of Molecular Sciences. 2022; 23(6): 3362
[Pubmed] | [DOI]
23 Membrane Interactivity of Capsaicin Antagonized by Capsazepine
Maki Mizogami, Hironori Tsuchiya
International Journal of Molecular Sciences. 2022; 23(7): 3971
[Pubmed] | [DOI]
24 Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical Evaluation
Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam, Mohd Yasir, Omar Awad Alsaidan, Ali Alquraini, Alenazy Rawaf, Bader Alsuwayt, Md. Khalid Anwer, Sultan Alshehri, Mohammed M. Ghoneim
Pharmaceutics. 2022; 14(3): 507
[Pubmed] | [DOI]
25 A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA
Ioana Toma, Alina Silvia Porfire, Lucia Ruxandra Tefas, Ioana Berindan-Neagoe, Ioan Tomu?a
Pharmaceutics. 2022; 14(7): 1482
[Pubmed] | [DOI]
26 Probing influence of nanocarrier structure on red blood cell membrane perturbations
Aishwarya Jain,Sharvil Patil
Materials Technology. 2021; : 1
[Pubmed] | [DOI]
27 Quality by Design for Optimizing a Novel Liposomal Jojoba Oil-Based Emulgel to Ameliorate the Anti-Inflammatory Effect of Brucine
Marwa H. Abdallah, Heba S. Elsewedy, Amr S. AbuLila, Khaled Almansour, Rahamat Unissa, Hanaa A. Elghamry, Mahmoud S. Soliman
Gels. 2021; 7(4): 219
[Pubmed] | [DOI]
28 Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles
Antonio José Guillot,Enrique Jornet-Mollá,Natalia Landsberg,Carmen Milián-Guimerá,M. Carmen Montesinos,Teresa M. Garrigues,Ana Melero
Pharmaceutics. 2021; 13(3): 418
[Pubmed] | [DOI]
29 Challenges in the Physical Characterization of Lipid Nanoparticles
Supandeep Singh Hallan,Maddalena Sguizzato,Elisabetta Esposito,Rita Cortesi
Pharmaceutics. 2021; 13(4): 549
[Pubmed] | [DOI]
30 Improving the Antitumor Activity and Bioavailability of Sonidegib for the Treatment of Skin Cancer
Amr Gamal,Haitham Saeed,Fatma I. Abo El-Ela,Heba F. Salem
Pharmaceutics. 2021; 13(10): 1560
[Pubmed] | [DOI]
31 The Impact of Improving Dermal Permeation on the Efficacy and Targeting of Liposome Nanoparticles as a Potential Treatment for Breast Cancer
Heba F. Salem, Amr Gamal, Haitham Saeed, Alaa S. Tulbah
Pharmaceutics. 2021; 13(10): 1633
[Pubmed] | [DOI]
32 Liposomes Loaded with Unsaponifiable Matter from Amaranthus hypochondriacus as a Source of Squalene and Carrying Soybean Lunasin Inhibited Melanoma Cells
Erick Damian Castañeda-Reyes,Elvira Gonzalez de Mejia,Fred Joseph Eller,Mark A. Berhow,María de Jesús Perea-Flores,Gloria Dávila-Ortíz
Nanomaterials. 2021; 11(8): 1960
[Pubmed] | [DOI]
33 When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications
Kazuaki Taguchi,Yuko Okamoto,Kazuaki Matsumoto,Masaki Otagiri,Victor Chuang
Pharmaceuticals. 2021; 14(4): 296
[Pubmed] | [DOI]
34 Nanoparticles use for Delivering Ursolic Acid in Cancer Therapy: A Scoping Review
Andang Miatmoko, Ester Adelia Mianing, Retno Sari, Esti Hendradi
Frontiers in Pharmacology. 2021; 12
[Pubmed] | [DOI]
35 Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin
Islam M Adel,Mohamed F ElMeligy,Mohamed EA Abdelrahim,Amr Maged,AbdelFattah A Abdelkhalek,Azza MM Abdelmoteleb,Nermeen A Elkasabgy
International Journal of Nanomedicine. 2021; Volume 16: 2667
[Pubmed] | [DOI]
36 Implementing Spanlastics for Improving the Ocular Delivery of Clotrimazole: In vitro Characterization, Ex vivo Permeability, Microbiological Assessment and In vivo Safety Study
Manar Adel Abdelbari,Shereen Sameh El-mancy,Ahmed Hassen Elshafeey,Aly Ahmed Abdelbary
International Journal of Nanomedicine. 2021; Volume 16: 6249
[Pubmed] | [DOI]
37 Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis
Prativa Biswasroy,Deepak Pradhan,Biswakanth Kar,Goutam Ghosh,Goutam Rath
AAPS PharmSciTech. 2021; 22(5)
[Pubmed] | [DOI]
38 Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation
Raju Saka,Naveen Chella,Wahid Khan
AAPS PharmSciTech. 2021; 22(5)
[Pubmed] | [DOI]
39 Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small cell lung cancer
Khushboo Patel,Chellampillai Bothiraja,Ashwin Mali,Ravindra Kamble
Particulate Science and Technology. 2021; : 1
[Pubmed] | [DOI]
40 Fail-safe nano-formulation of prodrug of sulfapyridine: Preparation and evaluation for treatment of rheumatoid arthritis
Bhupinder Kapoor,Monica Gulati,Sachin K. Singh,Gopal L. Khatik,Reena Gupta,Rakesh Kumar,Rajan Kumar,K. Gowthamarajan,Sanjeev Mahajan,Som Gupta
Materials Science and Engineering: C. 2021; 118: 111332
[Pubmed] | [DOI]
41 Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways
Shaimaa S. Ibrahim,Omar G. Abo Elseoud,Mohamed H. Mohamedy,Mohamed M. Amer,Youssef Y. Mohamed,Shehab A. Elmansy,Mohamed M. Kadry,Ahmed A. Attia,Ragy A. Fanous,Mahmoud S. Kamel,Youssef A. Solyman,Mazen S. Shehata,Mina Y. George
Neuropharmacology. 2021; : 108738
[Pubmed] | [DOI]
42 Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method
Josep Merlo-Mas,Judit Tomsen-Melero,José-Luis Corchero,Elisabet González-Mira,Albert Font,Jannik N. Pedersen,Natalia García-Aranda,Edgar Cristóbal-Lecina,Marta Alcaina,Rosa Mendoza,Elena Garcia-Fruitós,Teresa Lizarraga,Susanne Resch,Christa Schimpel,Andreas Falk,Daniel Pulido,Míriam Royo,Simó Schwartz,Ibane Abasolo,Jan Skov Pedersen,Dganit Danino,Andreu Soldevila,Jaume Veciana,Santi Sala,Nora Ventosa,Alba Córdoba
The Journal of Supercritical Fluids. 2021; : 105204
[Pubmed] | [DOI]
43 Galactosylated Chitosan Coated Liposomes of Ledipasvir for Liver Targeting: Chemical Synthesis, Statistical Optimization, In-vitro and In-vivo evaluation
Ahmed M. Fatouh,Ahmed H. Elshafeey,Ahmed Abdelbary
Journal of Pharmaceutical Sciences. 2021; 110(3): 1148
[Pubmed] | [DOI]
44 Systematic Characterization of Nanostructured Lipid Carriers from Cetyl Palmitate/Caprylic Triglyceride/Tween 80 Mixtures in an Aqueous Environment
Ni’matul Izza,Keishi Suga,Yukihiro Okamoto,Nozomi Watanabe,Tham Thi Bui,Yusuf Wibisono,Cut Rifda Fadila,Hiroshi Umakoshi
Langmuir. 2021; 37(14): 4284
[Pubmed] | [DOI]
45 Artificial neural networks in tandem with molecular descriptors as predictive tools for continuous liposome manufacturing
Sameera Sansare,Tibo Duran,Hossein Mohammadiarani,Manish Goyal,Gowtham Yenduri,Antonio Costa,Xiaoming Xu,Thomas OæConnor,Diane Burgess,Bodhisattwa Chaudhuri
International Journal of Pharmaceutics. 2021; 603: 120713
[Pubmed] | [DOI]
46 Formulation, characterization, optimization and in-vivo evaluation of methazolamide liposomal in-situ gel for treating glaucoma
Vaishali Y. Londhe, Sushmita Sharma
Journal of Drug Delivery Science and Technology. 2021; : 102951
[Pubmed] | [DOI]
47 Ascorbyl palmitate effects on the stability of curcumin-loaded soybean phosphatidylcholine liposomes
Junhua Li,Cuihua Chang,Jiali Zhai,Yanjun Yang,Haitao Yu
Food Bioscience. 2021; : 100923
[Pubmed] | [DOI]
48 A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy
Behzad Baradaran,Ali Mohammadi,Sara Shamekhi,Nikoo Majidazar,Azita Dilmaghani,Saiedeh Razi Soofiyani,Nigel AJ McMillan,Farzaneh Lotfipour,Somayeh Hallaj-Nezhadi
Drug Delivery and Translational Research. 2021;
[Pubmed] | [DOI]
49 Synthesis of Ag(I)@Fum-Pr-Pyr-Benzimidazole and Its Optical and Catalytic Activities in Click Reactions
Mahdieh Darroudi,Ghodsi Mohammadi Ziarani,Jahan B. Ghasemi,Alireza Badiei
ChemistrySelect. 2021; 6(24): 6168
[Pubmed] | [DOI]
50 Development of hybrid vesicular nanosystems composed of lipids and chitosan for octyl methoxycinnamate encapsulation
Natalia Ruben Castro,Cristal dos Santos C. Pinto,Vânia Emerich B. de campos,Verônica Cardoso,Alane Beatriz Vermelho,Elisabete P. dos Santos,Claudia Regina E. Mansur
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020; : 125476
[Pubmed] | [DOI]
51 Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs
Xuqian Li,Andy Samuel Widjaya,Jingxuan Liu,Xiao Liu,Zhiguo Long,Yanyan Jiang
Acta Biomaterialia. 2020;
[Pubmed] | [DOI]
52 Separation and characterization of liposomes using asymmetric flow field-flow fractionation with online multi-angle light scattering detection
Ángela Écija-Arenas,Vanesa Román-Pizarro,Juan Manuel Fernández-Romero
Journal of Chromatography A. 2020; : 461798
[Pubmed] | [DOI]
53 Formulation development and in vitro evaluation of transferrin-conjugated liposomes as a carrier of ganciclovir targeting the retina
Rathapon Asasutjarit,Chittima Managit,Teva Phanaksri,Worapapar Treesuppharat,Asira Fuongfuchat
International Journal of Pharmaceutics. 2020; : 119084
[Pubmed] | [DOI]
54 A supercritical fluid technology for liposome production and comparison with the film hydration method
Noémie Penoy,Bruno Grignard,Brigitte Evrard,Géraldine Piel
International Journal of Pharmaceutics. 2020; : 120093
[Pubmed] | [DOI]
55 A concise review of metallic nanoparticles encapsulation methods and their potential use in anticancer therapy and medicine
Bartosz Skóra,Konrad A. Szychowski,Jan Gminski
European Journal of Pharmaceutics and Biopharmaceutics. 2020;
[Pubmed] | [DOI]
56 EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells
Josimar O. Eloy,Amalia Ruiz,Felipe Tita de Lima,Raquel Petrilli,Giovanni Raspantini,Karina Alexandre Barros Nogueira,Elias Santos,Carlos Sabino de Oliveira,Júlio César Borges,Juliana Maldonado Marchetti,Wafa T. Al-Jamal,Marlus Chorilli
Colloids and Surfaces B: Biointerfaces. 2020; : 111185
[Pubmed] | [DOI]
57 Ethanol injection technique for liposomes formulation: An insight into development, influencing factors, challenges and applications
Ahmed Gouda,Omar S. Sakr,Maha Nasr,Omaima Sammour
Journal of Drug Delivery Science and Technology. 2020; : 102174
[Pubmed] | [DOI]
58 The kinetics of photostabilization of cyanocobalamin in liposomal preparations
Adeel Arsalan,Iqbal Ahmad,Syed Abid Ali,Kiran Qadeer,Shaukat Mahmud,Fozia Humayun,Anwar Ejaz Beg
International Journal of Chemical Kinetics. 2020; 52(3): 207
[Pubmed] | [DOI]
59 Recent advancements in liposome-targeting strategies for the treatment of gliomas: A systematic review
JIE LI,Tiantian Tan,Liping Zhao,Mengmeng Liu,Yu You,Yiying Zeng,Dajing Chen,Tian Xie,Lele Zhang,Chaomei Fu,Zhao Wu Zeng
ACS Applied Bio Materials. 2020;
[Pubmed] | [DOI]
60 Treatment of Basal Cell Carcinoma Via Binary Ethosomes of Vismodegib: In Vitro and In Vivo Studies
Amr Gamal F,Ossama M. Sayed,Fatma I. Abo El-Ela,Rasha M. Kharshoum,Heba F. Salem
AAPS PharmSciTech. 2020; 21(2)
[Pubmed] | [DOI]
61 Effect of Formulation Variables and Gamma Sterilization on Transcorneal Permeation and Stability of Proniosomal Gels as Ocular Platforms for Antiglaucomal Drug
Sinar Sayed,Mostafa Abdelmoteleb,Maha M. Amin,Omnia M. Khowessah
AAPS PharmSciTech. 2020; 21(3)
[Pubmed] | [DOI]
62 Increased Encapsulation Efficiency of Methotrexate in Liposomes for Rheumatoid Arthritis Therapy
Diana Guimarães,Jennifer Noro,Ana Loureiro,Franck Lager,Gilles Renault,Artur Cavaco-Paulo,Eugénia Nogueira
Biomedicines. 2020; 8(12): 630
[Pubmed] | [DOI]
63 Nanoliposome Precursors for Shape Modulation: Use of Heuristic Algorithm and QBD Principles for Encapsulating Phytochemicals
Sameer J. Nadaf,Suresh G. Killedar
Current Drug Delivery. 2020; 17(7): 599
[Pubmed] | [DOI]
64 Silymarin Spray-Dried Proliposomes: Preparation, Characterization and Cytotoxic Evaluation
Ahmed Gardouh,Sherif Shaker,Zainab Z. Ali,Mamdouh Ghorab
Drug Delivery Letters. 2020; 10(1): 14
[Pubmed] | [DOI]
65 Quercetin Loaded Monolaurate Sugar Esters-Based Niosomes: Sustained Release and Mutual Antioxidant—Hepatoprotective Interplay
Enas Elmowafy,Marwa O. El-Derany,Francesca Biondo,Mattia Tiboni,Luca Casettari,Mahmoud E. Soliman
Pharmaceutics. 2020; 12(2): 143
[Pubmed] | [DOI]
66 Continuous-Flow Production of Liposomes with a Millireactor under Varying Fluidic Conditions
Fatih Yanar,Ali Mosayyebi,Claudio Nastruzzi,Dario Carugo,Xunli Zhang
Pharmaceutics. 2020; 12(11): 1001
[Pubmed] | [DOI]
67 Redox-Responsive Heparin–Chlorambucil Conjugate Polymeric Prodrug for Improved Anti-Tumor Activity
Abegaz Tizazu Andrgie,Yihenew Simegniew Birhan,Tefera Worku Mekonnen,Endiries Yibru Hanurry,Haile Fentahun Darge,Rong-Ho Lee,Hsiao-Ying Chou,Hsieh-Chih Tsai
Polymers. 2019; 12(1): 43
[Pubmed] | [DOI]
68 Influence of stabilising agents on the properties of liposomal encapsulated ethanolic coconut husk extract
Oladipupo Odunayo Olatunde,Soottawat Benjakul,Kitiya Vongkamjan,Thanaporn Amnuaikit
International Journal of Food Science & Technology. 2019;
[Pubmed] | [DOI]
69 Ascorbic acid derivative-loaded modified aspasomes: formulation, in vitro, ex vivo and clinical evaluation for melasma treatment
Mona H. Aboul-Einien,Soha M. Kandil,Ebtsam M. Abdou,Heba M. Diab,Marwa S.E. Zaki
Journal of Liposome Research. 2019; : 1
[Pubmed] | [DOI]
70 A comprehensive review on recent preparation techniques of liposomes
C. Has,P. Sunthar
Journal of Liposome Research. 2019; : 1
[Pubmed] | [DOI]
71 Control of liposomes diameter at micrometric and nanometric level using a supercritical assisted technique
P. Trucillo,R. Campardelli,M. Scognamiglio,E. Reverchon
Journal of CO2 Utilization. 2019; 32: 119
[Pubmed] | [DOI]
72 Fabrication of levofloxacin polyethylene glycol decorated nanoliposomes for enhanced management of acute otitis media: Statistical optimization, trans-tympanic permeation and in vivo evaluation
Aly A. Abdelbary,Wessam H. Abd-Elsalam,Abdulaziz M. Al-mahallawi
International Journal of Pharmaceutics. 2019; 559: 201
[Pubmed] | [DOI]
73 Study on antibacterial finishing of cotton fabric with silver nanoparticles stabilized by nanoliposomes
Jidong Ru,Xueren Qian,Ying Wang
Cellulose. 2018;
[Pubmed] | [DOI]
74 Curcumin nanocochleates: Use of design of experiments, solid state characterization, in vitro apoptosis and cytotoxicity against breast cancer MCF-7 cells
Sameer J. Nadaf,Suresh G. Killedar
Journal of Drug Delivery Science and Technology. 2018;
[Pubmed] | [DOI]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article
Materials and Me...
   Article Figures

 Article Access Statistics
    PDF Downloaded1560    
    Comments [Add]    
    Cited by others 74    

Recommend this journal